State Street Corp Aqua Bounty Technologies, Inc. Transaction History

State Street Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.55 - $1.17 $49,720 - $105,768	-90,400 Reduced 32.72%	185,874 $111,000
Q4 2022 Feb 14, 2023	SELL	$0.6 - $17.32 $21,240 - $613,128	-35,400 Reduced 11.36%	276,274 $209,000
Q3 2022 Nov 15, 2022	SELL	$0.8 - $15.88 $41,520 - $824,172	-51,900 Reduced 14.27%	311,674 $243,000
Q2 2022 Aug 15, 2022	SELL	$1.18 - $2.04 $869,927 - $1.5 Million	-737,227 Reduced 66.97%	363,574 $622,000
Q1 2022 May 16, 2022	BUY	$1.34 - $2.26 $161,752 - $272,806	120,711 Added 12.32%	1,100,801 $2.06 Million
Q4 2021 Feb 14, 2022	BUY	$2.1 - $4.36 $95,726 - $198,746	45,584 Added 4.88%	980,090 $2.06 Million
Q3 2021 Nov 15, 2021	BUY	$3.9 - $5.67 $316,477 - $460,109	81,148 Added 9.51%	934,506 $3.8 Million
Q2 2021 Aug 16, 2021	BUY	$4.85 - $6.9 $4.01 Million - $5.71 Million	827,129 Added 3153.49%	853,358 $4.57 Million
Q1 2021 May 17, 2021	SELL	$6.09 - $12.2 $7,917 - $15,859	-1,300 Reduced 4.72%	26,229 $176,000
Q4 2020 Feb 16, 2021	BUY	$3.56 - $10.21 $98,003 - $281,071	27,529 New	27,529 $241,000

5.32M

Ticker AQB
Exchange NASDAQ
Sector Consumer Defensive
Industry Farm Products
Shares Outstandng 71,110,704
Market Cap $84.6M
Description
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sel...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.